Dr. Lisac is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2015 Uppergate Dr 400
Atlanta, GA 30322Phone+1 404-778-4834
Summary
- Robert Lisac is a Pediatric Blood and Marrow Transplant (BMT) and Cell Therapy Fellow at Emory University and Children’s Healthcare of Atlanta. His focus is on addressing long-term complications from graft-versus-host disease and enhancing survivorship care. Robert is actively involved with the ASTCT and CIBMTR and is dedicated to advancing research and improving clinical practices in pediatric BMT and cell therapy.
Education & Training
- Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2021 - 2024
- University of Florida College of Medicine JacksonvilleResidency, Pediatrics, 2018 - 2021
- University of Central Florida College of MedicineClass of 2018, MD
- Linfield CollegeBS, Biology, Cum Laude, 2008 - 2012
Certifications & Licensure
- GA State Medical License 2021 - 2026
- American Board of Pediatrics Pediatrics
- EpicPhysician Builder
- Institute for Healthcare ImprovementBasic Certificate in Quality & Safety
Awards, Honors, & Recognition
- Deputy of the American Society for Transplantation and Cellular Therapy American Society for Transplantation and Cellular Therapy (ASTCT), 2024
- Warshaw Fellow Research Award Emory University, 2023
- Red Ribbon Young Investigator and Travel Award Pediatric Transplantation and Cellular Therapy Consortium (PTCTC), 2023
- Join now to see all
Publications & Presentations
PubMed
- 100 citationsAndrogen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc UpregulationLina Gao, Jacob Schwartzman, Angela Gibbs, Robert Lisac, Richard Kleinschmidt
Plos One. 2013-05-21 - 11 citationsCellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor.Daniel J. Coleman, Kathryn Van Hook, Carly J. King, Jacob Schwartzman, Robert Lisac
Oncotarget. 2016-06-03 - 8 citationsIntegrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer.Carly J. King, Josha Woodward, Jacob Schwartzman, Daniel J. Coleman, Robert Lisac
Oncotarget. 2017-11-20
Professional Memberships
- Member
- American Society of Pediatric Hematology/Oncology - ASPHOMember
- American Society for Transplantation and Cellular Therapy - ASTCTMember
- Children's Oncology Group - COGMember
- Member
- Pediatric Transplantation and Cellular Therapy Consortium - PTCTCMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: